The Vaccination plan started and the elderly waited around for months before they were able book an appointment. It wasn't a great plan by NYC politicians. They should left it to the medical field personnel for proper planning. The saga continues.
The European Medicines Agency (EMA), the European Union's drug regulator, found a possible link between Johnson & Johnson's COVID-19 vaccine and rare cases of blood clotting in deep veins.
During a Pharmacovigilance Risk Assessment Committee meeting, the agency said it found a possible link between venous thromboembolism (VTE) and the J&J vaccine.
The agency also recommends that immune thrombocytopenia (ITP) be listed as a side effect of the J&J vaccine and AstraZeneca's vaccine.
ITP is a bleeding disorder in which "the immune system mistakenly targets blood cells called platelets that are needed for normal blood clotting," the agency wrote.